Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

por Colin, Philippe, Ringe, Rajesh P., Yasmeen, Anila, Ozorowski, Gabriel, Ketas, Thomas J., Lee, Wen-Hsin, Ward, Andrew B., Moore, John P., Klasse, P. J.
Publicado 2023

Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

por Colin, Philippe, Ringe, Rajesh P., Yasmeen, Anila, Ozorowski, Gabriel, Ketas, Thomas J., Lee, Wen-Hsin, Ward, Andrew B., Moore, John P., Klasse, P.J.
Publicado 2023

HIV-1 evades virus-specific IgG2 and IgA class switching by targeting systemic and intestinal B cells via long-range intercellular conduits

por Xu, Weifeng, Santini, Paul A., Sullivan, John S., He, Bing, Shan, Meimei, Ball, Susan C., Dyer, Wayne B., Ketas, Thomas J., Chadburn, Amy, Cohen-Gould, Leona, Knowles, Daniel M., Chiu, April, Sanders, Rogier W., Chen, Kang, Cerutti, Andrea
Publicado 2009

Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies

por Chung, Nancy PY, Matthews, Katie, Kim, Helen J, Ketas, Thomas J, Golabek, Michael, de los Reyes, Kevin, Korzun, Jacob, Yasmeen, Anila, Sanders, Rogier W, Klasse, Per Johan, Wilson, Ian A, Ward, Andrew B, Marozsan, Andre J, Moore, John P, Cupo, Albert
Publicado 2014

SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates

por Murphy, Elisabeth A., Guzman-Cardozo, Camila, Sukhu, Ashley C., Parks, Debby J., Prabhu, Malavika, Mohammed, Iman, Jurkiewicz, Magdalena, Ketas, Thomas J., Singh, Sunidhi, Canis, Marie, Bednarski, Eva, Hollingsworth, Alexis, Thompson, Embree M., Eng, Dorothy, Bieniasz, Paul D., Riley, Laura E., Hatziioannou, Theodora, Yang, Yawei J.
Publicado 2023

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate

por Dey, Antu K., Cupo, Albert, Ozorowski, Gabriel, Sharma, Vaneet K., Behrens, Anna‐Janina, Go, Eden P., Ketas, Thomas J., Yasmeen, Anila, Klasse, Per J., Sayeed, Eddy, Desaire, Heather, Crispin, Max, Wilson, Ian A., Sanders, Rogier W., Hassell, Thomas, Ward, Andrew B., Moore, John P.
Publicado 2017

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C

por Klasse, P. J., LaBranche, Celia C., Ketas, Thomas J., Ozorowski, Gabriel, Cupo, Albert, Pugach, Pavel, Ringe, Rajesh P., Golabek, Michael, van Gils, Marit J., Guttman, Miklos, Lee, Kelly K., Wilson, Ian A., Butera, Salvatore T., Ward, Andrew B., Montefiori, David C., Sanders, Rogier W., Moore, John P.
Publicado 2016

Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva

por Ketas, Thomas J., Chaturbhuj, Devidas, Cruz-Portillo, Victor M, Francomano, Erik, Golden, Encouse, Chandrasekhar, Sharanya, Debnath, Gargi, Diaz-Tapia, Randy, Yasmeen, Anila, Leconet, Wilhem, Zhao, Zhen, Brouwer, Philip J.M., Cushing, Melissa M., Sanders, Rogier W., Cupo, Albert, Klasse, P. J., Formenti, Silvia C., Moore, John P.
Publicado 2021

Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers

por Ringe, Rajesh P., Ozorowski, Gabriel, Rantalainen, Kimmo, Struwe, Weston B., Matthews, Katie, Torres, Jonathan L., Yasmeen, Anila, Cottrell, Christopher A., Ketas, Thomas J., LaBranche, Celia C., Montefiori, David C., Cupo, Albert, Crispin, Max, Wilson, Ian A., Ward, Andrew B., Sanders, Rogier W., Klasse, P. J., Moore, John P.
Publicado 2017

Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin

por Ringe, Rajesh P., Cruz Portillo, Victor M., Dosenovic, Pia, Ketas, Thomas J., Ozorowski, Gabriel, Nogal, Bartek, Perez, Lautaro, LaBranche, Celia C., Lim, Jillian, Francomano, Erik, Wilson, Ian A., Sanders, Rogier W., Ward, Andrew B., Montefiori, David C., Nussenzweig, Michel C., Klasse, P. J., Cupo, Albert, Moore, John P.
Publicado 2020

Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection

por Veazey, Ronald S., Klasse, Per Johan, Ketas, Thomas J., Reeves, Jacqueline D., Piatak, Michael, Kunstman, Kevin, Kuhmann, Shawn E., Marx, Preston A., Lifson, Jeffrey D., Dufour, Jason, Mefford, Megan, Pandrea, Ivona, Wolinsky, Steven M., Doms, Robert W., DeMartino, Julie A., Siciliano, Salvatore J., Lyons, Kathy, Springer, Martin S., Moore, John P.
Publicado 2003

Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health

por Racine-Brzostek, Sabrina E, Yang, He S, Jack, Gwendolyne A, Chen, Zhengming, Chadburn, Amy, Ketas, Thomas J, Francomano, Erik, Klasse, P J, Moore, John P, McDonough, Kathleen A, Girardin, Roxanne C, Dupuis, Alan P, Payne, Anne F, Ma, Lucy X, Sweeney, Jacob, Zhong, Elaine, Yee, Jim, Cushing, Melissa M, Zhao, Zhen
Publicado 2021

Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva

por Ketas, Thomas J., Chaturbhuj, Devidas, Portillo, Victor M Cruz, Francomano, Erik, Golden, Encouse, Chandrasekhar, Sharanya, Debnath, Gargi, Díaz-Tapia, Randy, Yasmeen, Anila, Kramer, Kyle D., Munawar, Tarek, Leconet, Wilhelm, Zhao, Zhen, Brouwer, Philip J.M., Cushing, Melissa M., Sanders, Rogier W., Cupo, Albert, Klasse, Per Johan, Formenti, Silvia C., Moore, John P.
Publicado 2021

Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons

por Prabhu, Malavika, Yang, Yawei J., Johnston, Carrie D., Murphy, Elisabeth A., Ketas, Thomas J., Diaz-Tapia, Randy, Jurkiewicz, Magdalena, Racine-Brzostek, Sabrina, Mohammed, Iman, Sukhu, Ashley C., Singh, Sunidhi, Forlenza, Kimberly, Iyer, Sonali, Yee, Jim, Eng, Dorothy, Marks, Kristen, Zhao, Zhen, Klasse, Per Johan, Permar, Sallie, Moore, John P., Riley, Laura E.
Publicado 2023

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

por Sanders, Rogier W., Derking, Ronald, Cupo, Albert, Julien, Jean-Philippe, Yasmeen, Anila, de Val, Natalia, Kim, Helen J., Blattner, Claudia, de la Peña, Alba Torrents, Korzun, Jacob, Golabek, Michael, de los Reyes, Kevin, Ketas, Thomas J., van Gils, Marit J., King, C. Richter, Wilson, Ian A., Ward, Andrew B., Klasse, P. J., Moore, John P.
Publicado 2013

Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques

por Klasse, P. J., Ketas, Thomas J., Cottrell, Christopher A., Ozorowski, Gabriel, Debnath, Gargi, Camara, Diawoye, Francomano, Erik, Pugach, Pavel, Ringe, Rajesh P., LaBranche, Celia C., van Gils, Marit J., Bricault, Christine A., Barouch, Dan H., Crotty, Shane, Silvestri, Guido, Kasturi, Sudhir, Pulendran, Bali, Wilson, Ian A., Montefiori, David C., Sanders, Rogier W., Ward, Andrew B., Moore, John P.
Publicado 2018

Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens

por Antanasijevic, Aleksandar, Ueda, George, Brouwer, Philip J. M., Copps, Jeffrey, Huang, Deli, Allen, Joel D., Cottrell, Christopher A., Yasmeen, Anila, Sewall, Leigh M., Bontjer, Ilja, Ketas, Thomas J., Turner, Hannah L., Berndsen, Zachary T., Montefiori, David C., Klasse, Per Johan, Crispin, Max, Nemazee, David, Moore, John P., Sanders, Rogier W., King, Neil P., Baker, David, Ward, Andrew B.
Publicado 2020

SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia

por Qin, Kai, Honjo, Kazuhito, Sherrill-Mix, Scott, Liu, Weimin, Stoltz, Regina, Oman, Allisa K., Hall, Lucinda A., Li, Ran, Sterrett, Sarah, Frederick, Ellen R., Lancaster, Jeffrey R., Narkhede, Mayur, Mehta, Amitkumar, Ogunsile, Foluso J., Patel, Rima B., Ketas, Thomas J., Cruz Portillo, Victor M, Cupo, Albert, Larimer, Benjamin M., Bansal, Anju, Goepfert, Paul A., Hahn, Beatrice H., Davis, Randall S.
Publicado 2022

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

por Qin, Kai, Honjo, Kazuhito, Sherrill-Mix, Scott, Liu, Weimin, Stoltz, Regina M., Oman, Allisa K., Hall, Lucinda A., Li, Ran, Sterrett, Sarah, Frederick, Ellen R., Lancaster, Jeffrey R., Narkhede, Mayur, Mehta, Amitkumar, Ogunsile, Foluso J., Patel, Rima B., Ketas, Thomas J., Cruz Portillo, Victor M., Cupo, Albert, Larimer, Benjamin M., Bansal, Anju, Goepfert, Paul A., Hahn, Beatrice H., Davis, Randall S.
Publicado 2023

Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients

por Yang, He S., Racine-Brzostek, Sabrina E., Karbaschi, Mohsen, Yee, Jim, Dillard, Alicia, Steel, Peter A.D., Lee, William T., McDonough, Kathleen A., Qiu, Yuqing, Ketas, Thomas J., Francomano, Erik, Klasse, P.J., Hatem, Layla, Westblade, Lars, Wu, Heng, Chen, Haode, Zuk, Robert, Tan, Hong, Girardin, Roxanne C., Dupuis, Alan P., Payne, Anne F., Moore, John P., Cushing, Melissa M., Chadburn, Amy, Zhao, Zhen
Publicado 2021